✦ LIBER ✦

A randomized, double-blind, placebo-controlled study of a cathepsin-K inhibitor in the treatment of postmenopausal women with Low BMD: 18 month results

✍ Scribed by Avery Ince; Michael McClung; Henry Bone; Nadia Verbruggen; Andrea Rybak-Feiglin; Carolyn daSilva; Arthur Santora

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four-month treatment with GLP-2 signific

✍ Dennis B. Henriksen; Peter Alexandersen; Bolette Hartmann; Charlotte L. Adrian; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 897 KB

Treatment with the cathepsin K inhibitor

✍ B. Langdahl⁎; N. Binkley; H. Bone; N. Gilchrist; H. Resch; J. Rodriguez Portales 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Treatment with the cathepsin K inhibitor

✍ H. Resch; N. Binkley; H. Bone; J.A. Eisman; N. Gilchrist; B. Langdahl; J. Rodrig 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Effect of the Cathepsin K Inhibitor Odan

✍ Stoch, S A; Zajic, S; Stone, J; Miller, D L; Van Dyck, K; Gutierrez, M J; De Dec 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 306 KB

Two year results in a randomized, double

✍ J.A. Eisman; R.R. Recker; M. McClung; H. Bone; C. Roux; N. Verbruggen; C.M. Hust 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Psychological assessment of the effects

✍ Maria Luisa Casini; Guido Marelli; Enrico Papaleo; Augusto Ferrari; Francesco D’ 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB